Presenters’ biography and abstract of paper
2013 NATPA annual meeting
Prof. Wentai Liu (劉文泰教授)
Title：Engineering Hope with Biomimetic Systems (仿生系統創造希望)
Biography
Wentai Liu received a B.S. degree from National Chiao-Tung University in Taiwan, a M.S.
degree from National Taiwan University, and a Ph.D. from the University of Michigan. In 1983,
he joined North Carolina State University, where he held the Alcoa Chair Professorship in
electrical and computer engineering and was the founder of the Analog/Mixed-Mode Design
Consortium. In 2003-2011, he was a professor in the electrical engineering at the University of
California, Santa Cruz, where he was also the campus director of the NSF Engineering Research
Center on Biomimetic Microelectronic Systems. Currently he is a Distinguished Professor in the
Bioengineering Department at the University of California at Los Angeles. His research interests
include neuro-engineering, neural prosthesis, brain-machine interface, bioelectronics. Since its
early stages, he has been leading the engineering efforts of the retinal prosthesis to restore vision,
leading to successful implant tests in blind patients. The venture finally leaded to successful
commercial implants (code name as Argus-II) for blind patients, receiving both CE Mark in 2011
and USA FDA market approval in Feb 2013. He has published more than 300 technical papers
and is a co-author of Wave Pipelining: Theory and CMOS Implementation (Kluwer Academic).
He received 2009 R&D-100 Editor Choice Award, 2010 Popular Mechanics Breakthrough
Invention Award, Outstanding Paper Awards from IEEE-CVPR (1986) and ACCV (2009)
Conferences, Alcoa Foundation’s Distinguished Engineering Research Award, NASA Group
Achievement Award, and both Outstanding Alumni Award and Honorary Doctoral Degree from
National Chiao-Tung University, Taiwan. He has served as guest editors for IEEE proceeding
and IEEE Trans. on MTT and is currently an Associate Editor for both IEEE Trans. on
Biomedical Engineering and IEEE Trans. on Bio-Circuits and Systems. He is also an ISSCC
Subcommittee member. He is a co-founder of the International Conference on Neuroprosthetic
Devices (ICNPD).
Abstract
Biomimetic research has progressed rapidly in the recent years fueled by the unique
interdisciplinary efforts fusing engineering, medicine, and biology. It has to address the aspects
of humanity and societal impacts, technical challenges and barriers, targeting a wide range of
applications. They span from understanding the highly complex biological systems, to
treating/restoring/repairing the lost biological functions such as deafness, blindness, seizure, and
paralysis, to building human-machine interface for performance enhancement. Biomimetic
systems will offer viable solutions and thus provide hope to those people with neural disorder
diseases, which currently do not have curable solutions but potentially affect very large
population of people worldwide. This talk will first present the opportunity, challenge, and the
enabling technologies to realize integrated and miniaturized biomimetic systems. Then the
retinal prosthesis will be presented, including the creation and invention, technical
challenge/barrier, clinical trials result, market opportunity, and leading to Europe CE Mark and
USA FDA Approval. The story is about the scientific creation, determination, and perseverance.
Dr. Chih-wei Chang (張志瑋博士)
Title: Micromachined Neural Interface for Biomedical Applications
Biography
Chihwei Chang received the B.S., M.S. and Ph.D. degrees in Electrical and Control Engineering
from National Chiao-Tung University, Taiwan, in 2003, 2005 and 2011, respectively. From 2011
to 2012, he was a Postdoctoral Researcher with Department of Electrical Engineering, National
Chiao-Tung University. He is now a Postdoctoral Researcher in Department of Bioengineering,
University of California, Los Angeles. His research interests are in the areas of BioMEMS,
implantable bioelectronics, neural interface design, signal processing and biomedical
engineering.
Abstract
Brain-implantable devices have a promising future. Implantable neural sensing devices are
currently viewed as an approach for brain function investigation and neural prostheses
realization. Implantable neural interface designs are always required to provide stable
observation on monitoring targets including epilepsy and seizures with small packaging and
biocompatible properties as well. Such biomedical devices are usually including circuits and
electrodes, the former provide signal conditioning, processing and transmission while the latter
collect biopotentials from the target volume of tissue. Therefore, miniaturized and highly
integrated implantable microsystems are the key solution to capture accurate signals from an
untethered subject in his natural habitat. In this talk, different kinds of electrode designs from
non-invasive to fully implantable application and from single device fabrication to single-chipintegrated interface design will be discussed in this talk.
Dr. Wu, Hung-Jen (吳泓仁教授)
Title: Antibody-Free Detection of M. tuberculosis Specific Antigens with
Nanoporous Silica Thin-Films
Biography
Dr. Hung-Jen Wu is currently appointed as a Research Associate in the Nanomedicine
Department at the Methodist Hospital Research Institute, and is involved in developing
diagnostic tools for infectious diseases. He received his Bachelor’s and Master’s degrees from
the National Cheng-Kung University, Taiwan. Dr. Wu received his Ph.D. in chemical
engineering from Texas A&M University in 2006, working on developing advanced microscopy
techniques to explore weak molecular interactions. From 2007 to 2011, he worked as a postdoctoral fellow at the University of California, Berkeley. During the postdoctoral training, he
focused on studying the properties of cell membrane. Dr. Wu’s research primarily focuses on the
development of nanostructured materials for diagnosis of diseases, including cancer and
infectious diseases (tuberculosis and HIV).
Abstract
The most prevalent and deadliest infectious disease, tuberculosis (TB), caused by
Mycobacterium tuberculosis (M. tuberculosis) is one of the leading public health problems. TB
control and prevention majorly rely on early diagnosis of active TB and directly observed
therapy (DOT), due to the lack of an effective vaccine. The diagnostic and screening methods
currently available are hindered by low sensitivity and/or specificity in the discrimination of TB
infection and active TB disease. Rapid and accurate diagnosis of active TB remains a major
challenge for global efforts to control TB. Here, we developed an antibody-free assay that
integrated a mass spectrometry with a fractionation system based on Nanoporous Silica ThinFilms (NSTFs) to quantitatively detect M. tuberculosis specific antigens from the biological
samples. The proteins and peptides can be selectively enriched from biological fluids by
engineering physicochemical properties of the NSTF (pore size, pore structure, and surface
affinity) We successfully established a NSTF with specific nanopore properties that can isolate
the low molecular weight antigens (ESAT-6 & CFP-10) for mass spectrometry detection. Our
final goal is to develop a real-time detection and quantitative analysis device of M. tuberculosis
specific antigens for the monitoring of disease progress and the efficacy of anti-TB therapy.
Dr. Perry B. Shieh (謝泊怡教授)
Title: Treatments for Genetic Neuromuscular Diseases
Biography
Perry B. Shieh is Associate Professor of Neurology, director of the Neuromuscular Division at
UCLA Medical Center, and director of the UCLA Neuromuscular Medicine Fellowship training
program. He completed B.A. in physics at U.C. Berkeley, his M.A. in physics at Harvard, and
his M.D. and Ph.D. at Johns Hopkins, where his Ph.D. dissertation focused on molecular
mechanisms of neuroplasticity (i.e. learning and memory) in the Department of
Neuroscience. His current interest is in the treatment of neuromuscular diseases, and his
research is focused on development of treatments for patients of neuromuscular disease.
Abstract
Our understanding of genetic disease has progressed significantly over the past few decades.
With improved understanding of the genetic basis for many genetic diseases, there has been an
effort to design new treatments that would specifically target gene defects. This form of
"personalized medicine" would require doctors to provide treatments based on the specific
genetic mutation that patient has. This presentation will discuss emerging therapies that have
been or are being developed by the pharmaceutical industry for patients with genetic
neuromuscular diseases. The strategies that will be discussed include: 1) enzyme replacement
therapy, 2) exon skipping with antisense oligonucleotide therapy, 3) splicing modulation with
antisense oligonucleotide therapy, 4) stop codon suppression with a small molecule, 5) targeted
transcript degradation with antisense oligonucleotide therapy.
Prof. Tzung K. Hsiai (解宗德教授)
Title: Hemodynamics and Mechanotransduction: From Zebrafish to Human
Atherosclerosis
Biography
Tzung Hsiai received his undergraduate education in bioengineering from Columbia University
and his MD from the University of Chicago. He completed his internship, residency and
cardiovascular fellowship at UCLA School of Medicine, where he further pursued NIH-funded
post-graduate training in Biomedical Engineering in 2001. His research interest is primarily in
mechanobiology of cardiovascular diseases. His group developed the first quantitative microtechnological approach to couple changes in intravascular shear stress with vascular oxidative
stress in the rabbit model. In collaboration with the developmental biologists, his group has
recently developed a zebrafish model to study electromechanical coupling of injured and
regenerating hearts. In collaboration with the environmentalists, his group is assessing vascular
oxidative stress in response to ambient ultrafine nanoparticles. He has been actively contributing
to the Biomedical Engineering Society and American Physiological Society Joint Symposiums
with Biomedical Engineering (FASEB). He is a member of the American Society for Clinical
Investigation, NIH Bioengineering, Technology, and Surgical Sciences Study Section, a Fellow
of American College of Cardiology, and the recipient of an American Heart Association John J.
Simpson Outstanding Research Achievement Award.
Abstract
Atherosclerosis is a systemic disease; however, its manifestations tend to be focal and eccentric.
The spatial (/x) and temporal (/t) components of shear stress largely determine the focal
nature of vascular oxidative stress and pro-inflammatory states. By integrating quantitative and
biomolecular approaches, we have demonstrated that the combination of intravascular shear
stress (ISS) and electrochemical impedance spectroscopy (EIS) distinguishes pre-atherogenic
lesions associated with oxidative stress in fat-fed NZW rabbits. We have further demonstrated
that the use of zerafish system enables us to elucidate shear stress-activated developmental genes
with translational implication for vascular repair. In this context, we are embarking on a journey
from shear stress in the developmental zebrafish model to pathophysiological model of
atherosclerosis. By coupling intravascular shear stress with endoluminal electrochemical
impedance, we seek to identify high-risk patients for individualized intervention.
Dr. Frank P.K. Hsu(徐博高教授)
Title: Cerebral Aneurysms (腦血管瘤之探討)
Biography
Frank P.K. Hsu, M.D, Ph.D. is a professor, vice chair, and residency program director of the
department of Neurological Surgery at University of California, Irvine. Clinically he specializes
in cerebrovascular, minimally invasive and open skull base surgery. He has extensive expertise
in radiosurgery and functional surgery for movement disorders, deep brain stimulation, epilepsy
and pain. His research interests include biomechanics of cerebral aneurysms and application of
technology in medicine. He attended Johns Hopkins University and University of Maryland. He
did his residency at Oregon Health Sciences University and his fellowship at Barrow
Neurological Institute. He then served as the vice chair and director of cerebrovascular and skull
base center at the Loma Linda University Medical Center for 9 years prior to joining UC Irvine.
Abstract
Cerebral aneurysm is a clinically relevant problem causing subarachnoid hemorrhage
(SAH). SAH is a devastating condition. In this presentation we will discuss the clinical
presentation of cerebral aneurysms and its management. We will also discuss the pathogenesis
and biomechanics of cerebral aneurysms.
Prof. Chin-Lin Guo (郭青齡教授)
Title: Mechanics-driven Self-organization in Tissue-scale Tubulogenesis
Biography
Chin-Lin Guo (郭青齡) graduated from National Taiwan University, with a M.D. and a M.S. in
Electrical Engineering (advisor: Jynpyng Wang 汪治平). He obtained his Ph.D. in Physics at
University of California, San Diego (advisor: Herbert Levine, con-mentor: Shu Chien, Terence
Hwa), and postdoctoral training at Harvard University, Molecular and Cell Biology department
(advisor: Andrew W Murray). He is now an assistant professor at California Institute of
Technology, Bioengineering. His research is to explore the physical mechanisms governing cell
polarization and tissue-scale self-organization.
Abstract
The ability of cells to self-organize into tissue-scale structures raises the possibility that an
understanding of such processes can lead to a scaffold-free approach to engineer organs for
regenerative medicine. However, the exact mechanisms of self-organization, particularly at
tissue-scale, are not well understood. Here, we investigate how adult epithelial cells use
mechanical processes to modify the surrounding microenvironments, by which they can selforganize into tissue-scale, functional tubules. We find two distinct behaviors. When surrounded
by 3-D extracellular matrix (ECM), cells can develop long-range mechanical interactions (up to
600 m), by which both normal and tumor cells develop long-range, synergistic invasion
phenotypes. In contrast, when ECM is limited, as in the early stage of embryogenesis, normal
cells can self-organize into tissue-scale functional tubules (up to centimeter-long, hundreds of
micrometer-wide), while tumor cells fail to form functional architectures. Our results provide a
novel framework for scaffold-free, tissue-scale engineering of organs and a quantitative platform
for investigating the phenotypic differences between normal and tumor cells.
Ya-yu Hew(丘雅鈺 女士)
Title: Wireless Strain Sensing System for Structural Health Monitoring in
Space
Biography
She graduated from Taipei First Girls High School in 2009, and came to the University of Texas
at Arlington the same year for her undergraduate degree in Aerospace Engineering and Physics.
She has been conducting research in the Advanced Sensor Technology Laboratory at UTA for
more than 2.5 year working on an independent research project in developing next generation
Structure Health Monitoring Wireless Strain Sensors. She received a full-ride graduate
fellowship from the Stanford University and is planning on continuing her Master/PhD study
there.
Abstract
The ongoing demand of the integrated space Vehicle Health Monitoring Systems (VHMS) has
been boosted by the increasing global interests in space exploration. Specifically, the wireless
sensor has the benefit of reducing the payload and the launch costs. Thus, lots of researchers
monitor the fundamental structural physical indicators – strain to study the spacecraft mechanical
performance. For spacecrafts, the Wireless Strain Sensor (WSS) will reveal the impact of
acoustics and vibration on vehicle or equipment during launching/ ground test. In the Rocket
Acoustics Program, NASA used WSN to monitor the structure strength of the Composite
Overwrapped Pressure Vessel (COPV).
This presentation presents the implementation and characterization of a wireless strain
measurement system that is powered by solar energy. This system includes a wireless strain
sensor that consumes about 6 mW, a wireless solar energy harvesting unit, and a frequency
modulation/demodulation unit. To achieve such an ultra-low power operation, a voltagecontrolled oscillator (VCO) is used to convert the direct-current (DC) strain signal to a high
frequency oscillatory signal. This oscillatory signal is then transmitted by an unpowered wireless
transponder. The sensor is powered by solar-based energy harvester. The frequency
demodulation will be implemented as a frequency counter implemented in a microcontroller
board (Arduino) and acquired using a PC-based MATLAB program. The system demonstrates
highly linear/repeatable structural static measurement, and is able to measure structural vibration.
The application of WSS in space is promising and bears the potential in cost reduction and
payloads with great scalability and sensor flexibility.
Cheng-Yu Wei(魏琤郁 女士)
Title: Cross Cultural Translation in Performance
Biography
Cheng-Yu (Miso) Wei is a freelance stage manager working internationally and regionally in
many diverse venues. She received two bachelor degrees of Theatre and Social Work from
National Taiwan University. In 2009, Ms. Wei received full scholarship from Taiwan Ministry of
Education, which allowed her to finish her degree of Master of Fine Arts (stage manager) from
UCSD, department theatre and dance and work with La Jolla Playhouse and the Old Globe. She
will be a visiting scholar at UCSD from 2013 to 2015.
She had multiple stage management credits in plays, operas, musicals, dance, tours, new works
and cooperate events both in America and Taiwan, American credits including: Francesca
Harper Dance Project at Alvin Ailey American Dance Theater, The Nightingale at La Jolla
Playhouse (directed by Moisés Kaufman), Chagall: A Dance Musical (directed by Tom
Dugdale), Nobody Loves You (directed by Michelle Tattenbaum)/Odyssey (directed by Lear
DeBessonet) at Old Globe, Golden Dragon (Harris Goldman Productions). The credits in Taiwan
include After Darwin (directed by Hong Zheng Fu), The Pillowman/Wonder of the World
(directed by Ci Zong Fan) and Q&A/Beauty and the Beast (directed by Bo Shen Lyu), The
Dining Room (directed by Yan Lin Huang), Hansel und Gretel (Taipei Symphony Orchestra) and
Der Ring des Nibelungen (National Symphony Orchestra). Her academic theatre credits include
Titus Andronicus (directed by Joshua Brody), June Moon (directed by Jonathan Silverstein), The
Thugs (directed by Eric Hunicutt), The Threepenny Opera (directed by Jeffrey Wienckowski),
Joe Turner’s Come and Gone (directed by Kyle Donnelly). Academic dance credits are Arts in
Actions: Connected (directed by Patricia Rincon), New Directions (directed by Liam Clancy &
Eric Geiger), WinterWorks (directed by Patricia Rincon).
Abstract
“Stage Management is a complex, highly specialized, and frequently misunderstood field.
Stage managers are the conductors of the performative process. They supply the artistic
continuity, creatively orchestrating the unfolding of process. Stage managers artfully integrate
the needs of a production as well as the personalities of all collaborators.” (Lisa Porter)
The Nightingale, a story revised from the traditional Hans Christian Andersen story that
takes place in China, was re-envisioned by the La Jolla Playhouse in the summer of 2012. The
theatrical production process was driven by the director, Moisés Kaufman, who led a group of
American collaborators to explore the integration and translation between East and West,
Ancient and Modern.
At the beginning of the process, the creative team incorporated many stereotypes to make
the play more “Chinese” in the storytelling. I had the impulse to contribute my knowledge
according to my cultural identity but felt that was not in alignment with my role as a stage
manager on the project. Later in the process, the colorblind casting choices generated nationwide
debates within the Asian American theatre and artistic communities. I confronted a crisis: do I
remain loyal to my own culture or to the theatre profession in the country where I am studying? I
started to ask myself: what do I do in a leadership position when I face bias against my ethnicity?
How can I identify, embrace and prioritize my different roles? I was confused about how to
position myself with the other people in the production. Like the Young Emperor in the story, I
chose to fulfill my duty according to my work title, but at the same time, I felt working in the
style of an American stage manager was not enough. I sought to engage my ethnic identity in my
work, blurring the boundaries between my job title and my humanity within the process.
I went through a period of disappointment and anger followed by understanding and acceptance
of the meaning I found in the project. My reflection on the process began when the show closed
and I started talking with trusted advisors and friends about the struggles I had experienced. I
slowly started to reflect on my identity and the bias and embraced the advantages and
disadvantages that come along with both. Step by step, I freed myself from the rigid perception
about Eastern and Western culture and started to think outside of the boxes that are created by
every culture. Ultimately, I understood that my nationality did not signify who I was and my
capabilities. I now approach both the Asian and American theatre worlds by looking for a place
to belong. My academic experience in America and The Nightingale gave me the chance to
observe how people from different cultures interacted and translated between one another and I
discovered a new space where the two worlds are integrated.
林婉筠(林婉筠 女士)
Title: 從文學現代性看台灣 (Modernity in Taiwan Literature)
Biography
林婉筠，國立政治大學中文系、政大台灣文學研究所畢業。研究現代主義、後現代主義與
現代文學，鍾愛詩體、符號與意義、歧義與悖論。
Abstract
日治時期「風車詩社」首創台灣的現代主義風格，提倡西方現代主義知性精神，兼及
超現實主義、意象派、立體派等二十世紀前衛實驗性的文學技巧，著重經營文字藝術美感。
在二○年代新詩詩體終於脫離舊詩體制的文學史進程中，三○年代的風車詩社繼續解放現
代詩詩風，無論文學形式或文學精神，都為殖民地台灣提供了新的美學視角。
由美學視角出發，以現代主義詩藝為主題，最終要回應的是三○年代風車詩人的文本經
由現代主義技術對語言進行的實驗及表現的態勢，其底下所揭露的現代主義經驗及現代詩
書寫主體的內部精神；風車詩人如何以創新的寫作手法引領出嶄新的美學形式，超現實主
義現代文學的銜接縫隙處，如何存有層次豐富的美學內涵。文本以超現實主義的美學在寫
作技巧上呈現了「主體的質疑」、「否定與匱缺」、「反諷與諧擬」、「快感與創傷」四
種修辭的形式，由這四種修辭表現出發探討風車詩作的美學形式、與精神分析有關的語言
研究、和文字間的深層涵義所包含的不斷環繞某些主題的思想痕跡。以此著眼觀察台灣由
現代化邁向後現代化帶來的個體主演變。
Kailin Gow (高凱琳女士)
Title: Combining Creativity and Technology for the Future
Biography
Besides being an international bestselling author with several of her books making the bestseller
lists on Amazon in many categories, Kailin Gow has been a principal and founder in the mid-size
publishing house, Sparklesoup Inc. She has appeared on top national syndicated talk shows such
as CBS/KCAL-TV News, ABC Radio, Barbara Dooley show, Chat with Women on KKNW
Seattle, Broadminded on Sirius Radio XM, and more as a leading authority on YA and women's
issues including self-esteem, body image, dating and sexual relationships, abuse, and bullying.
Kailin has been an author and publishing executive for over 12 years with over 100 titles
published under her name and under pen names.
Prior to becoming a full-time author, she held management positions in Fortune 500 corporations
in marketing at Hilton Hotels Corporation, Omni Hotels Corporation, and start up internet
companies; as well as worked in television and radio as a producer and writer.
She is also the founder of the community social site, The Saving You Saving Me Project,
http://www.savingyousavingme.com which helps teens, young adults, and women deal with
social issues like sexual abuse, self-esteem, body image, bullying, cutting, relationships, and
more in a positive community environment. The Saving You Saving Me Project is an extension
of her YA-mature fiction Saving You Saving Me.
Kailin Gow is a full-time author and speaker, who has lived in California, Nevada, Texas, and
England. Besides writing her next book, she is also involved in her community in the PTA, Girl
Scouts, and Moms Organizations, where she recommends books and gives talks about leadership
and other themes in her books.
Abstract
How do we tap into our creative selves as a constant resource? Why it is important and
even vital for us to get in touch with our creative side in order to accomplish more? How
do we, as ordinary people, achieve the extraordinary?
In this inspiring talk by bestselling author of over 100 creative fiction novels in several
categories including fantasy, science fiction, young adult, romance, and thriller; Kailin
Gow will talk about the creative process and how being able to tap into your constant
creativity combined with technology can achieve the extraordinary. She will talk about
her journey as someone who makes a living being creative, the obstacles she's had to
overcome to become a bestselling author, and how she is constantly tapping into her
creative side to expand upon the ordinary.
The following are the key points of her speech:
I. One Idea can Change the Future
A. History has shown us over and over again the power of that one idea.
B. Creativity gives flight to ideas.
II. Where do Ideas come from?
III. From Ordinary to Extraordinary
IV. When Creativity Meets Technology and how it opens the doors to the future
V. We are all inventors
Liu, Ta Tan, Chairman (劉大潭董事長)
Title: 用創意創造成功機會
Biology
一. 學歷:
1.西嶺國小第廿七屆畢業.
2.鳳鳴國中第一屆畢業.
3.國立台中高工機械製圖科畢業.
4.逢甲大學機械工程系畢業.
二. 經歷:
1.機械設計製圖研究發明工作32年.
2.台中發明學校—專任講師
三. 現職:
1.速跑得機械工業股份有限公司負責人.
2.南開科技大學講師.
3.中國醫葯大學發明研究社指導老師
四. 專長:
1. CNC 工作母機及自動化機械設計製造.
2. 電腦輔助設計,製圖,分析,模擬.
3. 專利新產品研發,製作.
4. 頭腦想到什麼産品,就可以用電腦3D 展現出來.
五. 得意作品:
1. 蜘蛛高樓逃生緩降機
2. 節省一半能源之安全電梯.
3. 緩衝起動馬達.
4. 電動控制閥.
5. 四面八方同時出風之多重選向電風扇.
6. 焚化爐專用耐高溫橢圓碟片閥門.
7. 微電腦全自動過濾八通閥.
六. 得獎摘要:
1. 機械製圖技能競賽金牌.
2. 全國發明展第一名.
3. 全國發明展金頭腦獎.
4. 瑞士日內瓦國際發明金牌
5. 德國國際發明金牌
6. 國科會十大傑出科技人才獎.
7. 文化復興運動總會科技總統獎.
8. 經濟部中小企業創新研究獎.
9. 金毅獎
10. 全球熱愛生命獎
11. 3D 立體製圖技能競賽金牌
12. 鉗工,機械組裝技能競賽金牌
Abstract
用創意創造成功機會
A.人生到處都需要創意.
B. 腿殘如何出國—設計 63 段變速車.
C. 腿殘如何開汽車--用螺絲起子開車.
D.廢物如何利用---到資源回收場取材
E. 看到學生因火災亡---發明緩降機.
F. 看到火葬場有臭氣---發明橢圓閥解決臭氣.
G.看到澳洲缺水---發明自動過濾六通閥.
H.看到連戰先生關在電梯---發明安全電梯.
I. 看到肌肉萎縮人---發明自動翻身床.
J. 看到草皮都是狗便---發明夾便器.
K.學生時代如何用創意賺學費.
L. 關懷是解決問題最佳依據.
Prof. Yvonne Lin(林韻玉教授)
Title: Harnessing Your Immune System to Combat Cancer
Biography
Yvonne Lin is an Assistant Professor of Obstetrics-Gynecology, Gynecologic Oncology at the
University of Southern California and Norris Comprehensive Cancer Center. After graduating
from the University of California, Irvine College of Medicine, she completed her obstetricsgynecology residency at the Beth Israel Deaconess Medical Center in Boston, MA, then her
gynecologic oncology fellowship at the University of Texas, M.D. Anderson Cancer Center. Her
research focuses on novel intracellular and protein pathways involved in the cellular response to
viral infection, metabolic stress, and tumor development. Her work has been presented at
national meetings and published in several high impact, peer-review journals. She has received
research funding from the Foundation for Women’s Cancer, Stop Cancer, the American Cancer
Society (ACS), and the Clinical and Translational Science Institute (CTSI). Her research has
been awarded the J.G. Moore Award for Outstanding Basic Science Presentation, the Diane
Denson Tobola Fellowship in Ovarian Cancer Research. She has been an active member of the
Gynecologic Oncology Group, where she is the national Study Chair of a Phase 1 trial studying
sequential ipilimumab after definitive chemoradiation for the primary treatment of cervical
cancer. Outside of work, Yvonne is an active alumna of the Massachusetts Institute of
Technology (MIT) where she is the current Vice-President of her Class and a new inductee to the
MIT Alumni Association Program Committee. Yvonne & her husband are also long-time
supporters of the Pasadena Humane Society where they adopted their Belgian Malinois, Sally.
Abstract
The discovery of tumor-associated antigens (TAAs) on tumors and a better understanding of the
patients’ immune responses to these antigens have opened the possibility of novel
immunotherapeutic strategies. Human papillomas virus (HPV) is the putative etiology of most
cervical cancers and can trigger the patient’s immune system in a virus-specific manner. Given
what we know about the immune response, new immune modulating therapies to harness the
immune system may represent promising treatment options for patients with cervical cancer.
Dr. Chris Fan (范清亮博士)
Title: Being healthy is no longer a dream
Biography
現職：
‧穩達生技及美商穩萊公司董事長、總裁兼執行長
學歷：
‧台灣大學化學學士 (1968) 及美國普渡大學生化博士 (1973)
經歷：
‧曾於美國成立兩家非常成功之生物科技公司，分別為 Pacific Biotech (1982)和
Wyntek Diagnostics (1994)，擔任此兩家公司總裁兼執行長。
‧1988 獲得「Arthur Young and Venture Magazine」頒發的年度「最佳企業獎」。
‧1998 獲得「聖地牙哥亞洲商業協會」頒發之「傑出企業家獎」。
Chong Ming (Chuck) Lee (李忠敏董事長)
Title: 由無變有小兵立大功 台灣之子 金屬零件生產製造廠商 春雨公司 創始
人 已故李春雨先生的故事。
Biography
本人出生於一九四一年 在高雄岡山 適逢當年日本偷襲珍珠港 在戰亂中長大。 大中小學
皆在台灣完成。一生皆與這種小小零件結了不斷之緣。 三十五歲來美。在美國加卅
Corona 開一小小公司 目前大部份業務己交下一代看管。正處於半退休期間。 正在盤算何
時全退。 希望在有生之年 計畫如何對美國社會及寶島故土...... 台灣 做些有用及實際的的
貢獻。
Abstract
講述這位百年難遇的一代偉人 從茅草廠房 一無所有開始 從事各種金屬零件 包括螺� 緊
固件 壓鑄件 彈簧 墊片 建築五金 等的全套總合企業。 這個企業包含了全套上下游一連串
體系 包括原料 及生產這些產品的機噐,工具,模具, 檢查用的各種量規 等皆萬事具全 皆自
己公司或子公司製造的。 再延伸下去 把整個台灣南部包括台南 高雄 屏東地區變成世界
生產基地。曾有一段期間 其輸出產品數量超過全世界生產量的一半 替台灣賺進無數外匯
一段期間 台灣外匯儲備 成為全世界僅次於日本的第二位。 更有進者 由春雨訓練出來的
離開後(畢業後) 自已創業當老闆的 " 春雨人 " ( Chun Yu Alumni )不下幾千人。 這些由 春雨
學校 出來 所發揮的力量更偉大 綜合起來比春雨公司大上幾十倍幾百倍。其足跡遍及台灣
全島,另又延伸到中國大陸及世界各地 其対這行事業的影響力已不可忽視 甚至連這位李
春雨先生在他有生之年亦想像不到的 他的子弟兵 有這麼偉大的成就。
Dr. John Hsu (徐新宏博士)
Title: 從無到有，創意經驗談
Biography
成長於農村，有機會到國外唸書是意外的事。
Ph.D. Mississippi State University Major: Agricultural Chemistry
曾服務於 Albion Laboratories, Inc., Utah 及 Utah State University
1987 創立 JH Biotech, Inc. 從事農業有機製劑之研究、生產及銷售。
1997 購併 CAPCO Environmental Services, Inc. 支援 JH Biotech, Inc. 之研究並加入環境汚染
之分析工作。
2008 成立 Novotech Nutraceuticals, Inc. 專注於有機健康食品原料之研究及生產。
曾任：
北美洲台灣人教授協會南加州分會會長
世界台灣客家聯合會會長
大洛杉磯台灣會館董事長
Abstract
從無到有，其中甘苦不是身入其境確實很難體驗。在這廿多年的創業生涯中累積了一些經
驗，提出來讓後來者參考。
從我自己的體驗，要讓事業從無到有並能持續，應有下列要件：
一、眼光：看得到目標才有可能達到目標。
二、態度：態度決定一切，放手一搏才有成功的希望。
三、善用學校、硏究機構資源。
四、營造工作環境，善用人才。
五、夫妻要同心。
創業初期必須先把願景做個槪略的描述，有了願景才能逐步訂下不同時期的目標，積小成
大，事業一定是逐步成長，不可能一夕登天。持著農夫的心境，一有空就下田，作物就會
在悉心呵護下成長。